Search
for

    Sort by

    Research 30 of 1000+

    1. Characters of KRT80 and its roles in neoplasms diseases Cancer medicine · 2023 · 2 citations
    2. Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in patients with breast cancer. Journal of Clinical Oncology · 2023
    3. Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome Cancer Treatment Reviews · 2023 · 7 citations
    4. Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Asia-Pacific Journal of Clinical Oncology · 2018 · 4 citations
    5. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer International Journal of Molecular Sciences · 2020 · 45 citations
    6. Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer Frontiers in Oncology · 2021 · 1 citations
    7. Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment Patient Preference and Adherence · 2021 · 12 citations
    8. A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib Journal of Comparative Effectiveness Research · 2024 · 7 citations
    9. The Safety of Testosterone Therapy in Women Journal of obstetrics and gynaecology Canada · 2012 · 11 citations
    10. Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment Journal of The American Academy of Dermatology · 2013
    11. Exploring obesity-related endocrine disorders beyond diabetes: a narrative review The Egyptian Journal of Internal Medicine · 2024 · 4 citations
    12. Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer Drugs & Therapy Perspectives · 1993
    13. Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis Frontiers in Endocrinology · 2022 · 5 citations
    14. Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review Pharmacological Reviews · 2022 · 49 citations
    15. Cold Atmospheric Plasma for Breast Cancer Preprints.org · 2026
    16. Oral minoxidil for late alopecia in cancer survivors Breast Cancer Research and Treatment · 2024 · 14 citations
    17. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects Frontiers in Endocrinology · 2021 · 59 citations
    18. Is dehydroepiandrosterone a hormone? Journal of Endocrinology · 2005 · 403 citations
    19. Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing IntechOpen eBooks · 2023 · 1 citations
    20. Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article Egyptian Journal of Medical Human Genetics · 2024 · 3 citations
    21. Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties Discover Oncology · 2026
    22. Actualités du SOPK Annales D Endocrinologie · 2006
    23. Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment Primary Care · 2007 · 21 citations
    24. Hormonal therapies for acne Clinics in Dermatology · 2016 · 26 citations
    25. Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care Comprehensive Therapy · 2002
    26. Sex hormones and related compounds, including hormonal contraceptives Side effects of drugs annual · 2014
    27. Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition Endocrine Reviews · 2005 · 451 citations
    28. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    29. Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents Annals of Oncology · 2005 · 67 citations
    30. Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer Medical Oncology · 2013 · 6 citations